These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12755548)

  • 41. Magnetic resonance imaging in renal transplantation.
    Neimatallah MA; Dong Q; Schoenberg SO; Cho KJ; Prince MR
    J Magn Reson Imaging; 1999 Sep; 10(3):357-68. PubMed ID: 10508297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal transit time with MR urography in children.
    Jones RA; Perez-Brayfield MR; Kirsch AJ; Grattan-Smith JD
    Radiology; 2004 Oct; 233(1):41-50. PubMed ID: 15317951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gd HP-DO3A--experimental evaluation in brain and renal MR.
    Runge VM; Gelblum DY; Jacobson S
    Magn Reson Imaging; 1991; 9(1):79-87. PubMed ID: 2056855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast-enhanced MR imaging of the female pelvis.
    Hricak H; Kim B
    J Magn Reson Imaging; 1993; 3(1):297-306. PubMed ID: 8428097
    [No Abstract]   [Full Text] [Related]  

  • 46. In vivo fluorine-19 MR imaging: relaxation enhancement with Gd-DTPA.
    Lee H; Price RR; Holburn GE; Partain CL; Adams MD; Cacheris WP
    J Magn Reson Imaging; 1994; 4(4):609-13. PubMed ID: 7949689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac MRI: estimation of changes in normalized myocardial gadolinium accumulation over time after contrast injection in patients with acute myocarditis and healthy volunteers.
    Breuckmann F; Maderwald S; Buhr C; Bruder O; Schlosser T; Erbel R; Barkhausen J; Nassenstein K
    Rofo; 2011 Oct; 183(10):933-8. PubMed ID: 21863535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of a spectral-spatial water excitation for MR angiography.
    Hatabu H; Gaa J; Stock KW; Li W; Thomasson D; Edelman RR
    Eur J Radiol; 1999 Mar; 29(3):253-8. PubMed ID: 10399611
    [No Abstract]   [Full Text] [Related]  

  • 49. Gadolinium-DTPA enhanced MR imaging of intradural neurenteric cysts.
    Pierot L; Dormont D; Queslati S; Cornu P; Rivierez M; Bories J
    J Comput Assist Tomogr; 1988; 12(5):762-4. PubMed ID: 3170836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
    Marcos HB; Semelka RC
    J Magn Reson Imaging; 1999 Dec; 10(6):950-60. PubMed ID: 10581508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement.
    Terk MR; de Verdier H; Colletti PM
    Magn Reson Imaging; 1993; 11(1):47-50. PubMed ID: 8423721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Gd-DTPA and fast gradient-echo and spin-echo MR imaging to demonstrate renal function in the rabbit.
    Carvlin MJ; Arger PH; Kundel HL; Axel L; Dougherty L; Kassab EA; Moore B
    Radiology; 1989 Mar; 170(3 Pt 1):705-11. PubMed ID: 2916024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs.
    Olsen UB
    Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gadolinium-enhanced liver magnetic resonance imaging using a 2-point Dixon fat-water separation technique: impact upon image quality and lesion detection.
    Rosenkrantz AB; Mannelli L; Kim S; Babb JS
    J Comput Assist Tomogr; 2011; 35(1):96-101. PubMed ID: 21160433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: preliminary report.
    Jinkins JR; Williams RF; Xiong L
    Invest Radiol; 1999 Feb; 34(2):156-9. PubMed ID: 9951796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gadolinium use in patients with kidney disease: a cause for concern.
    Perazella MA; Rodby RA
    Semin Dial; 2007; 20(3):179-85. PubMed ID: 17555477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase.
    Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G
    Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.
    Jackson EF; Esparza-Coss E; Wen X; Ng CS; Daniel SL; Price RE; Rivera B; Charnsangavej C; Gelovani JG; Li C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):830-8. PubMed ID: 17379450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statistical analysis of pharmacokinetic models in dynamic contrast-enhanced magnetic resonance imaging.
    Schmid VJ; Whitcher BJ; Yang GZ; Taylor NJ; Padhani AR
    Med Image Comput Comput Assist Interv; 2005; 8(Pt 2):886-93. PubMed ID: 16686044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.